Stocks›Healthcare›BIO

BIO

BIO-RAD LABORATORIES, INC.

NYSEResearch view

Healthcare · Laboratory Analytical Instruments · Large-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$10.3B

Enterprise Value$10.9B

Income$759.9M

Sales$2.6B

Book/sh$269.39

Cash/sh$19.24

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio4.19

Current Ratio5.62

Debt/Eq0.16

EPS (ttm)$27.85

EPS this Y142.6%

EPS past 3/5Y—

Sales past 3/5Y-2.7%

EPS Y/Y TTM142.6%

Sales Y/Y TTM0.7%

Shs Outstand27.67M

ROA7.2%

ROE10.2%

ROIC0.4%

Gross Margin51.9%

Oper. Margin1.8%

Profit Margin29.4%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$2.9B

2021

$2.8B

2022

$2.7B

2023

$2.6B

2024

$2.6B

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$2.9B	$2.8B	$2.7B	$2.6B	$2.6B
Gross Profit	$1.6B	$1.6B	$1.4B	$1.4B	$1.3B
Operating Income	$500.3M	$482.6M	$337.8M	$269.0M	$47.2M
Net Income	$4.3B	$-3.6B	$-637.3M	$-1.8B	$759.9M
Diluted EPS	$140.83	$-121.79	$-21.82	$-65.36	$27.85
Operating Cash Flow	$669.5M	$194.4M	$374.9M	$455.2M	$532.2M
Free Cash Flow	$535.7M	$81.6M	$218.2M	$289.6M	$374.6M